Importantly, the IGF/IGF-IR axis is not only involved in endocrine homeostasis but also plays a fundamental role in regulating cancer stem cells by sustaining their stemness, survival, and proliferative capabilities (154), suggesting that targeting this axis could have dual benefits: mitigating post-transplant complications and suppressing leukemia recurrence. The gene discussed is IGF1R; the disease is leukemia.